Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 247

JD Health jets towards IPO

JD.com’s healthcare spinoff has filed for an initial public offering after raising more than $1.9bn in equity funding from investors including Hillhouse Capital and Citic Capital.

Sep 30, 2020

KKday books up $75m series C

Alibaba, HIS and Line have all previously backed KKday, an online travel experience provider with more than 5 million registered users.

Sep 30, 2020

Inspiration Capital sparks $73m fund

Hexing Electrical, CSD Environment, Hailang Group and SIG are among the limited partners in a $73m fund raised by Qiming spinoff Inspiration Capital.

Sep 30, 2020

Inspiration Capital sparks $73m fund

Shanghai Jiao Tong University is among the limited partners in a $73m fund raised by Qiming spinoff Inspiration Capital.

Sep 30, 2020

SF Holdings helps package $308m fund

SF Holdings has joined forces with Citic Capital’s CCRE China Logistics to form a $308m fund that will focus on the logistics sector.

Sep 29, 2020

Logicreation thinks through $152m IPO

Tencent and Heyi Group are among the investors in line for an exit as Logicreation files to go public in China.

Sep 29, 2020

New Ruipeng picks up funding

Tencent has led a round worth hundreds of millions of dollars for New Ruipeng, which is now valued at $4.4bn and also backed by Boehringer Ingelheim and Country Garden.

Sep 29, 2020

XtalPi calculates $319m series C

SoftBank Vision Fund 2, PICC Group and Morningside Venture Capital co-led the round, which also attracted Tencent, China Life Insurance, SIG China and others.

Sep 28, 2020

Tencent helps transfer $176m to Taimei

Tencent joined GL Ventures and YF Capital to co-lead a $176m funding round for Taimei Technology, while SoftBank China Venture Capital also invested.

Sep 28, 2020

InventisBio ignites $147m series D

Lilly Asia Ventures has returned for a $147m series D round that will allow InventisBio to advance its treatments for breast cancer and gout into phase 2 clinical trials.

Sep 28, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here